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The thioflavin T fluorescence assay for amyloid fibril detection can be biased by
the presence of exogenous compounds
Abstract
Thioflavin T (ThT) dye fluorescence is used regularly to quantify the formation and inhibition of amyloid
fibrils in the presence of anti-amyloidogenic compounds such as polyphenols. However, in this study, it
was shown, using three polyphenolics (curcumin, quercetin and resveratrol), that ThT fluorescence should
be used with caution in the presence of such exogenous compounds. The strong absorptive and
fluorescent properties of quercetin and curcumin were found to significantly bias the ThT fluorescence
readings in both in situ real-time ThT assays and single time-point dilution ThT-type assays. The presence
of curcumin at concentrations as low as 0.01 and 1 uM was sufficient to interfere with the ThT
fluorescence associated with fibrillar amyloid-b(1-42) (0.5 uM) and fibrillar reduced and
carboxymethylated kappa-casein (50 lm), respectively. The ThT fluorescence associated with fibrillar
amyloid-b(1-42) was also biased using higher concentrations of resveratrol, a polyphenol that is not
spectroscopically active at the wavelengths of ThT fluorescence, implying that there can be direct
interactions between ThT and the exogenous compound and/or competitive binding with ThT for the
fibrils. Thus, in all cases where ThT is used in the presence of an exogenous compound, biases for
amyloid-associated ThT fluorescence should be tested, regardless of whether the additive is
spectroscopically active. Simple methods to conduct these tests were described. The Congo red spectral
shift assay is demonstrated as a more viable spectrophotometric alternative to ThT, but allied methods,
such as transmission electron microscopy, should also be used to assess fibril formation independently
of dye-based assays.
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Thioﬂavin T (ThT) dye ﬂuorescence is used regularly to quantify the formation and inhibition of amyloid ﬁbrils in the presence of anti-amyloidogenic compounds such as polyphenols. However, in this study, it was
shown, using three polyphenolics (curcumin, quercetin and resveratrol),
that ThT ﬂuorescence should be used with caution in the presence of such
exogenous compounds. The strong absorptive and ﬂuorescent properties of
quercetin and curcumin were found to signiﬁcantly bias the ThT ﬂuorescence readings in both in situ real-time ThT assays and single time-point
dilution ThT-type assays. The presence of curcumin at concentrations as
low as 0.01 and 1 lm was sufﬁcient to interfere with the ThT ﬂuorescence
associated with ﬁbrillar amyloid-b(1-42) (0.5 lm) and ﬁbrillar reduced and
carboxymethylated j-casein (50 lm), respectively. The ThT ﬂuorescence
associated with ﬁbrillar amyloid-b(1-42) was also biased using higher concentrations of resveratrol, a polyphenol that is not spectroscopically active
at the wavelengths of ThT ﬂuorescence, implying that there can be direct
interactions between ThT and the exogenous compound and ⁄ or competitive binding with ThT for the ﬁbrils. Thus, in all cases where ThT is used
in the presence of an exogenous compound, biases for amyloid-associated
ThT ﬂuorescence should be tested, regardless of whether the additive is
spectroscopically active. Simple methods to conduct these tests were
described. The Congo red spectral shift assay is demonstrated as a more
viable spectrophotometric alternative to ThT, but allied methods, such as
transmission electron microscopy, should also be used to assess ﬁbril
formation independently of dye-based assays.
Structured digital abstract
l
MINT-7259867: RCMj-CN (uniprotkb:P02668) and RCMj-CN (uniprotkb:P02668) bind
(MI:0407) by electron microscopy (MI:0040)
l
MINT-7258930: RCMj-CN (uniprotkb:P02668) and RCMj-CN (uniprotkb:P02668) bind
(MI:0407) by ﬂuorescence technologies (MI:0051)
l
MINT-7259878: Amyloid beta (uniprotkb:P05067) and Amyloid beta (uniprotkb:P05067) bind
(MI:0407) by ﬂuorescence technologies (MI:0051)

Abbreviations
CR, congo red; RCMj-CN, reduced and carboxymethylated j-casein; TEM, transmission electron microscopy; ThT, thioflavin T.
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Introduction
Over 40 debilitating and incurable human diseases are
associated with the failure of a speciﬁc peptide or protein to adopt, or remain in, its native functional state
[1]. These conditions are referred to as protein misfolding diseases and include pathologies as diverse as Alzheimer’s disease, Parkinson’s disease, cataracts and
type-II diabetes [1,2]. The majority of misfolding diseases are associated with amyloidosis, a pathological
state involving the self-aggregation of speciﬁc proteins
(or protein fragments) into cytotoxic ﬁlamentous
deposits known as amyloid ﬁbrils, which adopt a characteristic cross-b-sheet structure [1–3].
In this ﬁeld, extrinsic ﬂuorescence of the benzothiazole dye, thioﬂavin T (ThT), is widely used for the identiﬁcation and quantiﬁcation of amyloid ﬁbrils in vitro,
and has become the premier technique used to monitor
ﬁbrillation kinetics in real-time [4,5]. When ThT is
added to samples containing b-sheet-rich deposits, such
as the cross-b-sheet quaternary structure of amyloid
ﬁbrils, it ﬂuoresces strongly with excitation and emission maxima at approximately 440 and 490 nm,
respectively [6,7]. Free ThT in an aqueous environment, however, shows only weak ﬂuorescence, with
lower (blue-shifted) excitation and emission maxima at
350 and 440 nm, respectively [6]. Although the mechanism of interaction between ThT and amyloid ﬁbrils
remains poorly understood, the most widely accepted
theory involves the intercalation of ThT molecules
within grooves between solvent-exposed side chains of
the amyloid ﬁbril that run parallel to the ﬁbril axis
[5,8,9]. Binding within the channels is thought to provide rigidity and to prevent the formation of a
less-radiative twisted internal charge-transfer state of
the ThT molecule in the excited singlet state, which is
normally accompanied by growth of the torsion angle
between the benzthiazole and benzene ring from 37 to
90 [10]. As there is a stoichiometric and saturable
interaction between ThT and amyloid ﬁbrils, ﬂuorescence from the amyloid–ThT complex provides accurate quantiﬁcation of amyloid ﬁbril formation as a
function of amyloid ﬁbril length and number [4]. In
the so-called ThT ﬂuorescence assay, ThT is simply
added to samples containing ﬁbril structures at a concentration in excess of the number of potential ThT–
ﬁbril binding sites, and steady-state ThT ﬂuorescence
emission is monitored at  490 nm (excitation at
 440 nm). There are two common variations to this
assay: the in situ real-time ThT assay, whereby ﬁbril
formation is carried out in the presence of ThT, thus
providing a means to monitor ﬁbrillation kinetics in
real-time; and a single time-point dilution ThT assay,

in which samples of a ﬁbril-forming polypeptide are
diluted into buffered solutions of ThT, providing simpler single time-point readings.
Over the past 5 years, a wide range of compounds,
known as anti-amyloids (or anti-aggregates), have been
reported to prevent amyloid ﬁbril formation, reverse
ﬁbrillation and to protect against amyloid ﬁbrilinduced cytotoxicity [11–15]. One class of compounds
that has received considerable attention is the natural
polyphenols, which comprise over 8000 plant-derived
molecules found in high concentrations in wine, tea,
spices and berries [16,17]. For instance, recent studies
of the most abundant polyphenolic extract from green
tea, (-)-epigallocatechin-3-gallate, show that it efﬁciently suppresses ﬁbril formation by a-synuclein and
amyloid-b, the amyloidogenic proteins involved in Parkinson’s and Alzheimer’s diseases respectively, and
redirects their aggregation down an off-pathway yielding nontoxic unstructured oligomers [18]. We have
recently reported that (-)-epigallocatechin-3-gallate also
inhibits ﬁbril formation by the milk protein, reduced
and carboxymethylated j-casein (RCMj-CN), through
a distinct mechanism whereby the protein is
constrained in its native-like state [19]. The phenolic
aromatic rings of polyphenols are often connected via
conjugated systems, resulting in strong p ﬁ p* electronic transitions and making them chromophoric and
even intrinsically ﬂuorescent [20–22]. This spectroscopic activity commonly occurs at the principal wavelengths of ThT ﬂuorescence, which in theory makes
the ThT ﬂuorescence assay unsuitable for studies
where the ﬁbril-forming polypeptide is mixed with such
compounds. However, when reviewing the literature
on polyphenols, it is found that despite the caution of
such practices by LeVine [23], the ThT ﬂuorescence
assay is employed widely in the presence of such
polyphenols (i.e. as a means to assess their anti-amyloid activity) [24–34]. In fact, it is of concern that in
many studies the ThT technique is used as the sole
measure of the in vitro anti-aggregation efﬁcacy of
these compounds [24,27,30,32–34].
In this study, we illustrated the potential unsuitability of ThT as a probe for amyloid ﬁbril formation in
the presence of exogenous additives by examining the
effect of three polyphenols (curcumin, quercetin and
resveratrol) on the ﬂuorescence emission of ThT in
both in situ real-time ThT assays and single time-point
dilution ThT-type assays. We utilized the generic
model amyloid ﬁbril-forming protein with which we
have considerable experience, namely RCMj-CN,
which is easily prepared and is highly amyloidogenic
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under conditions of physiological temperature and pH,
and does not require denaturants [35,36]. As theorized,
it is found that the presence of the polyphenols signiﬁcantly biases the RCMj-CN ﬁbril-associated ThT ﬂuorescence, and these ﬁndings are corroborated using
ﬁbrillar amyloid-b(1-42) peptide [37]. The use of the
absorptive dye, Congo red (CR), is demonstrated as a
viable alternative to ThT, but it is also stressed that
other methods, such as transmission electron microscopy (TEM) should be used to assess ﬁbril formation
independently of dyes.

Results
The coupled effect of polyphenols on amyloid
fibril formation and on the in situ real-time ThT
assay
In order to explore the coupled effects of the selected
polyphenolics, curcumin, quercetin and resveratrol
(Fig. 1A), on amyloid ﬁbril formation and on in situ
real-time ThT ﬂuorescence, a solution of native
RCMj-CN (50 lm) containing ThT (10 lm) was incubated at 37 C in the presence and absence of the
polyphenols (1–100 lm) and the change in ThT

ﬂuorescence emission was monitored (Fig. 1). As previously reported, the initial decrease in in situ ThT ﬂuorescence emission during the ﬁrst 30 min of incubation
is attributable to the samples warming to the incubation temperature [36]. This was conﬁrmed by monitoring the temperature-dependence of ThT ﬂuorescence
induced with ﬁbrillar RCMj-CN (Fig. S1). The ThT
ﬂuorescence of RCMj-CN incubated alone increased
rapidly after the equilibration period and reached a
plateau after 800–1000 min, which is indicative of
RCMj-CN amyloid ﬁbril formation (0, Fig. 1B–D)
[35,36]. The addition of quercetin led to a concentration-dependent decrease in the apparent ThT ﬂuorescence (Fig. 1B), which on its own suggests the efﬁcient
concentration-dependent inhibition of ﬁbril formation.
Resveratrol, at concentrations up to 100 lm, had little
effect on the ThT ﬂuorescence response up to 400 min,
and only a small concentration-dependent decrease in
ﬂuorescence was observed at later time-points
(Fig. 1C). In stark contrast to the effects of quercetin
and resveratrol, the apparent ThT ﬂuorescence was
found to vary markedly with the concentration of
curcumin (Fig. 1D). At a concentration of 1–10 lm,
curcumin increased the apparent ThT ﬂuorescence,
whereas at 50 and 100 lm, the ﬂuorescence was

A

B

C

D

Fig. 1. Effect of the polyphenols, quercetin, resveratrol and curcumin, on RCMj-CN amyloid fibril formation and the associated increase in
in situ ThT fluorescence. (A) The structure of ThT and the polyphenols used in this study. (B–D) In situ real-time ThT fluorescence assays of
solutions of fresh native RCMj-CN (50 lM) incubated at 37 C in the presence of quercetin (B), resveratrol (C) and curcumin (D). For each
assay, polyphenol (100 lM) without RCMj-CN was also monitored (control). Values shown are the mean readings from three individual
experiments, and the standard error for each data point is within 4% (not visible).
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decreased, implying an inhibition of amyloidogenesis.
When the polyphenols were incubated with ThT in the
absence of RCMj-CN, there was no signiﬁcant change
in ThT ﬂuorescence over the course of the incubation
period, indicating that they do not form amyloid ﬁbrils
themselves, nor are they likely to interact directly with
free, solvated ThT (control, Fig. 1B–D).
Curcumin, quercetin and resveratrol affect
RCMj-CN fibril morphology with similar efficacy
The morphological effects of the polyphenols on
RCMj-CN aggregation were assessed simultaneously
by TEM (Fig. 2). In agreement with our previous studies [35,36], TEM micrographs of RCMj-CN alone,
taken before ﬁbril formation, indicated that RCMjCN exists initially as globular micelle-like species with
diameters of  30 nm (Fig. 2A). At plateaus of the
in situ ThT ﬂuorescence curves (i.e. post-incubation),
most preﬁbrillar entities have been incorporated into
mature amyloid ﬁbrils (Fig. 2B). In contrast to the

Fig. 2. TEM micrographs of samples from
the in situ ThT fluorescence assays (see
Fig. 1), taken before or after the 1100 min
incubation period to investigate the morphological effects of quercetin, resveratrol and
curcumin on RCMj-CN aggregation. (A)
Fresh native RCMj-CN (50 lM) before incubation, (B) RCMj-CN alone (50 lM) following incubation and (C–E) RCMj-CN (50 lM)
in the presence of polyphenols (100 lM)
after incubation: quercetin (C), resveratrol
(D) and curcumin (E). Bars represent
200 nm.

previous in situ real-time ThT ﬂuorescence experiments, all polyphenols (at the same concentration)
appeared to affect RCMj-CN aggregation similarly,
giving a combination of stunted ﬁbrillar and preﬁbrillar assemblies when RCMj-CN was incubated in their
presence (Fig. 2C–E). To investigate this discrepancy
between the TEM and real-time ThT assays, in relation to the possibility that the polyphenols bias the
apparent ThT ﬂuorescence, the spectroscopic properties of ThT and the polyphenols in the presence of
ﬁbrils were examined more closely.
The spectroscopic activity of quercetin and
curcumin bias ThT fluorescence
To explore the spectroscopic relationships between
ThT and the polyphenols, UV-visible absorption spectra (320–650 nm) of curcumin, quercetin and resveratrol solutions (100 lm) were recorded (Fig. 3A). The
absorption spectrum of RCMj-CN (50 lm) + ThT
(10 lm), pre-incubated for 20 h to induce the forma-

A

B

C

D

E
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A

B

C

D

E

F

G

H

Fig. 3. UV-visible absorption, ThT interaction and steady-state fluorescence emission characteristics of curcumin, quercetin and resveratrol.
(A) The absorption spectra (320–650 nm) of curcumin, quercetin and resveratrol solutions (100 lM) are shown. Also shown is the absorption
spectrum of pre-incubated fibrillar RCMj-CN (50 lM) and ThT (10 lM). (B–D) Steady-state ThT fluorescence emission spectra (kex 440 nm,
kem 470–700 nm) of pre-incubated fibrillar RCMj-CN (50 lM) and ThT (10 lM) in the absence of polyphenols (0 lM). Quercetin (B), resveratrol
(C) or curcumin (D) were added at various concentrations (1–100 lM) and the fluorescence spectra were re-acquired immediately. (E)
Steady-state curcumin fluorescence emission spectra (kex 426 nm, kem 450–700 nm) of fresh native RCMj-CN (50 lM) with curcumin
(1–100 lM). The spectrum of curcumin (100 lM) without RCMj-CN is also shown (control). (F–H) Steady-state ThT fluorescence emission spectra (kex 440 nm, kem 470–650 nm) of fibrillar amyloid-b(1-42) (0.5 lM) and ThT (5 lM) in the absence of polyphenols (0 lM). Quercetin (F), resveratrol (G) or curcumin (H) were added at various concentrations (0.01–5 lM) and the fluorescence spectra were re-acquired immediately.

tion of ﬁbrils, was also acquired (20 h RCMj-CN and
ThT; Fig. 3A). At these concentrations, the broad
absorption bands of the highly conjugated chromophores of quercetin and curcumin (absorption maxima
at 374 and 426 nm, respectively) completely dominated
the ThT absorption (maxima at approximately
440 nm; i.e. the excitation wavelength for the ThT
ﬂuorescence assay). This implies that when quercetin
5964

and curcumin are present in the real-time ThT assay,
they will cause signiﬁcant inner ﬁlter effects leading to
effective quenching of the ThT ﬂuorescence (i.e. by
absorbing both the light intended to excite ThT and
the ThT ﬂuorescence radiation emitted). By contrast,
resveratrol showed no absorption above 350 nm and
is thus unlikely to inﬂuence ThT ﬂuorescence on a
spectroscopic basis (Fig. 3A).
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Next, the direct effect of the polyphenols on the
ThT ﬂuorescence emission spectrum (kex 440 nm, kem
470–700 nm) was examined by adding curcumin, quercetin or resveratrol (1–100 lm) to pre-incubated ﬁbrillar RCMj-CN (50 lm) and ThT (10 lm) (Fig. 3B–D).
The ﬂuorescence spectra were acquired immediately
after the addition of the polyphenol. As hypothesized,
the addition of quercetin at high concentrations
(100 lm) signiﬁcantly decreased the ThT ﬂuorescence
yield (37% at 490 nm) (Fig. 3B) and the presence of
resveratrol did not alter the ThT ﬂuorescence spectra
from ﬁbrillar RCMj-CN alone (Fig. 3C). Based on
these data, the real-time ThT ﬂuorescence assay for
RCMj-CN treated with resveratrol (Fig. 1C) appeared
not to be inﬂuenced by resveratrol, therefore indicating
that resveratrol has little anti-aggregation activity
against RCMj-CN. The concentration-dependent inhibition effect observed for quercetin (Fig. 1B) is, however, clearly affected by quenching of the ThT
ﬂuorescence and cannot be attributed solely to an
inhibitory effect on ﬁbril formation (compare Fig. 1B
with Fig. 2C). Curcumin added at low concentrations
(1, 5 and 10 lm) enhanced the apparent emission of
ThT ﬂuorescence, but at higher concentrations
(100 lm) the ﬂuorescence yield was substantially
decreased (Fig. 3D). Furthermore, the spectrum shape
was altered, with the maximum emission wavelength
increasing (red-shifted) at higher concentrations of
curcumin.
These results for curcumin may be explained by
recent studies showing that although curcumin is
weakly ﬂuorescent in water, it becomes highly ﬂuorescent in aqueous solutions containing detergents and as
a result of binding to hydrophobic regions on proteins
such as human serum albumin or bovine serum albumin [22,38,39]. This implies that curcumin will become
ﬂuorescent in the presence of amyloid ﬁbril-forming
proteins, such as RCMj-CN, which inherently have
exposed hydrophobic regions that mediate the process
of aggregation [2,36]. Hence, intrinsic curcumin ﬂuorescence may contribute to the apparent real-time ThT
ﬂuorescence (Fig. 1D) and this may help to explain the
different ThT-interfering effects observed for curcumin
and quercetin (compare Fig. 3B with Fig. 3D). To
verify this, the steady-state curcumin ﬂuorescence
emission spectra (kex 426 nm, kem 450–700 nm) of
freshly prepared native RCMj-CN (50 lm) with curcumin (1–100 lm) were acquired (Fig. 3E). The control
curcumin solution (100 lm) showed weak ﬂuorescence.
As postulated, for all concentrations of curcumin in
the presence of RCMj-CN (50 lm), the ﬂuorescence
yield of curcumin was substantially enhanced. The
emission intensity was maximal up to a saturation
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concentration of curcumin of between 10 and 50 lm.
At higher concentrations, the additional solvated and
nonﬂuorescent curcumin is likely to re-absorb the ﬂuorescence radiation, leading to self-quenching [40]. The
curcumin ﬂuorescence spectra are also red-shifted with
increasing concentrations, which suggests increased solvent relaxation [40]. Signiﬁcantly, the wavelength range
of curcumin ﬂuorescence emission overlaps signiﬁcantly with the emission spectrum of ThT ﬂuorescence
(compare Fig. 3B–D with Fig. 3E). Hence, the apparent
ThT ﬂuorescence spectrum in the presence of curcumin
would be inﬂuenced by a combination of both the
absorptive (subtractive) and ﬂuorescent (additive)
properties of free curcumin and solvent-shielded curcumin, respectively (depending on the concentration of
curcumin) (compare Fig. 3A with Fig. 3E). These spectral properties provide an explanation for the complex
proﬁles of ﬂuorescence observed for the in situ realtime ThT assay for RCMj-CN aggregation conducted
in the presence of curcumin (Fig. 1D).
Dilution ThT assay techniques do not overcome
the spectroscopic biases of polyphenols and
reveal the occurrence of nonspectral interference
effects
In the previous sections it is demonstrated that in situ
real-time ThT ﬂuorescence assays are heavily biased by
the presence of the polyphenols, quercetin and curcumin. These real-time ThT ﬂuorescence assays are performed typically with relatively high concentrations of
ﬁbril-forming polypeptide to necessitate amyloidogenesis. However, the effect of any exogenous compound
on ThT ﬂuorescence is, of course, relative to its concentration and the magnitude of ThT ﬂuorescence
emission (a function of ThT concentration, concentration and type of amyloidogenic protein under study,
temperature and the buffer system employed) [23,41].
Exploiting this fact, some studies suggest that the
ThT-interfering effects of additives to the ThT ﬂuorescence assay (particularly polyphenols), can be overcome by performing single time-point dilution ThT
assays where protein samples are diluted into a ThT
solution (i.e. thereby diluting out the effects of the
added chromophores while in theory maintaining a
sufﬁciently high intensity of ﬁbril-induced ThT
ﬂuorescence for detection) [25,26,28,29].
To investigate these claims and to substantiate the
previous ﬁndings made using RCMj-CN, dilution ThT
assays were performed using the standard dilute concentration of pre-incubated ﬁbrillar amyloid-b(1-42)
(0.5 lm). Curcumin, quercetin or resveratrol was then
added at concentration ranges that are typical of those
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used in previous studies [24–34] (Fig. 3FH). As seen
with RCMj-CN, the immediate addition of quercetin
to ﬁbrillar amyloid-b(1-42) led to a dramatic concentration-dependent decrease in ThT ﬂuorescence (i.e. a
42 and 60 % decrease in ﬂuorescence intensity was
observed at 490 nm upon the addition of 1 and 5 lm
quercetin, respectively) (Fig. 3F, compare with Fig. 3B).
The addition of resveratrol, by contrast, had a
markedly different effect on the ThT ﬂuorescence
induced with amyloid-b(1-42) in comparison to
RCMj-CN. The ThT ﬂuorescence yield was reduced
signiﬁcantly at the higher concentrations of resveratrol,
despite resveratrol being spectroscopically inactive in
the ThT ﬂuorescence range (Fig. 3A). For example,
there was a 39 % decrease in ThT ﬂuorescence intensity at 490 nm in the presence of 5 lm resveratrol
(Fig. 3G, compare with Fig. 3C). These ﬁndings clearly
indicate that nonspectroscopic-based interferences primarily account for this bias in the ThT ﬂuorescence.
Moreover, because there is insufﬁcient time for resveratrol to disrupt the highly stable ﬁbril complexes after
its initial addition, the effect is most likely to involve
direct interactions between resveratrol and ThT, or
competitive binding between resveratrol and ThT for
sites along the ﬁbril structure. The ThT ﬂuorescence
spectra of the samples with resveratrol were also monitored continuously over a period of 48 h, but there
was no signiﬁcant decrease in intensity after the large
initial decrease (data not shown). It therefore appears
that an equilibrium involving these nonspectral interactions is rapidly established. This nonspectroscopic
interference may not be observed in the same assay
with identical molar ratios of resveratrol to ﬁbrillar
RCMj-CN (Fig. 3C) as a result of the inherent variations in the make-up of the amyloid-b(1-42) and
RCMj-CN ﬁbrils, or simply because of the presence
of a greater concentration of ﬁbrillar RCMj-CN for
ThT. Alternatively, assuming that a competitive amyloid–resveratrol interaction is involved in both cases,
this may suggest that resveratrol has a greater afﬁnity
for amyloid-b(1-42) and displaces amyloid-bound ThT.
Curcumin exhibits a clear concentration-dependent
inhibitory effect on the ThT ﬂuorescence yield in the
presence of preformed amyloid-b(1-42) ﬁbrils, with no
signiﬁcant change observed in the shape of the emission spectrum (Fig. 3H). This effect was also markedly
different to that observed with RCMj-CN (Fig. 3D),
implying that, like quercetin, the spectral effects of
curcumin are primarily absorptive, such that, at the
diluted concentrations, curcumin is not adequately solvent-shielded by the hydrophobic peptide to become
ﬂuorescent. Curcumin modulates the ThT ﬂuorescence
to the greatest extent of all the studied polyphenols,
5966

giving dramatic interfering effects at a concentration
as low as 0.01 lm. Therefore, it is evident that even
after diluting ﬁbril samples, the low concentrations of
exogenous additive can still adversely bias the ThT
ﬂuorescence response. Moreover, when comparing
spectroscopic versus possible nonspectroscopic interference in the cases of quercetin and curcumin, it is clear
that spectroscopic effects are the prominent contributor to the interference of ThT ﬂuorescence by these
two polyphenols.
CR dye binding as an alternative to ThT
The CR dye is a less commonly used spectrophotometric alternative to ThT for easily quantifying amyloid
ﬁbril formation [5,42]. CR is structurally similar to
ThT and is believed to bind to b-sheet-rich structures
in a similar manner [8,43]. Binding induces a characteristic increase in absorption and red shift in the CR
absorption band from 490 to 540 nm [43,44]. Although
CR is known to partially inhibit ﬁbril formation and is
thus unsuitable for an in situ-type assay, its use in single time-point experiments (the CR spectral shift assay)
has been well established (i.e. where CR is added to
aliquots of ﬁbril-forming polypeptide and the CR
absorption band is recorded immediately) [42,45,46].
Because the CR spectral shift assay relies on obtaining
absorption spectra at longer wavelengths than used for
the ThT ﬂuorescence assay, it potentially enables the
quantiﬁcation of amyloid ﬁbrils in the presence of
coloured compounds that interfere with ThT ﬂuorescence (or possibly even other types of ThT-interfering
compounds) [7,42].
To investigate this possibility, the CR absorption
spectra (450–600 nm) of solutions of pre-incubated
ﬁbrillar RCMj-CN (50 lm) and CR (20 lm), with and
without added curcumin, quercetin or resveratrol
(100 lm), were recorded (Fig. 4A). The absorption
spectra were acquired immediately after the addition
of the polyphenol. The spectra of CR (20 lm) alone
was also recorded (CR only, Fig. 4A). For all mixtures, the absorption shoulder at 540 nm from the CR
control is indicative of CR binding to amyloid ﬁbrils
[43,44]. Importantly, it appears that the polyphenols
only affect the CR spectral shift curve as a result of
their spectroscopic properties, which can be easily
accounted for via subtraction of the absorption spectrum of a control solution. For instance, the CR spectra of ﬁbrillar RCMj-CN in the presence and absence
of quercetin or resveratrol are identical, as both quercetin and resveratrol do not absorb signiﬁcantly over
the range of 450–600 nm (Fig. 3A). However, the
chromophore of curcumin does absorb considerably
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A

B

Fig. 4. The Congo red (CR) spectral shift assay as an alternative to ThT fluorescence for quantifying amyloid fibril formation in the presence
of curcumin, quercetin and resveratrol. (A) CR absorption spectra (450–600 nm) of pre-incubated fibrillar RCMj-CN (50 lM) and CR (20 lM)
in the absence of polyphenols (20 h RCMj-CN with CR). Curcumin, quercetin or resveratrol (100 lM) were added and the absorption spectra
were re-acquired immediately. The spectrum of CR alone (20 lM) is also shown. The strong spectral contribution from curcumin is clearly
visible below 520 nm. This has been accounted for by subtracting the absorption spectrum of a solution containing curcumin alone (100 lM)
(see Fig. 3A). (B) CR absorbance, at 540 nm, of fresh native RCMj-CN (50 lM) or RCMj-CN (50 lM), which was incubated at 37 C for 20 h
in the presence and absence of quercetin, resveratrol or curcumin (100 lM). All samples have CR (20 lM) added immediately before reading
the absorbance. For samples with curcumin, the absorbance readings were corrected for the contribution from the curcumin chromophore
by subtracting the absorbance at 540 nm of a solution of curcumin alone (100 lM) (see Fig. 3A). Values represent mean ± SEM (n = 6); NS,
not significantly different; *P < 0.05 and ***P < 0.001 versus RCMj-CN pre-incubated at 37 C for 20 h alone (one-way ANOVA, Dunnett’s
post hoc test).

over these wavelengths, but subtraction of the absorption spectrum of the control solution of curcumin
alone (Fig. 3A) resulted in a spectrum identical to that
of ﬁbrillar RCMj-CN alone [compare 20 h RCMjCN with CR and curcumin (corrected), Fig. 4A]. In a
similar assay, performed using native RCMj-CN
(50 lm) instead of ﬁbrillar RCMj-CN (because CR,
like ThT, partially binds native RCMj-CN), no difference in the absorption spectra were observed in the
presence and absence of the polyphenols after the spectral properties of curcumin alone were taken into
account (data not shown). Therefore, because the studied polyphenols do not signiﬁcantly affect CR-binding
or its subsequent absorptive properties, it appears that
the CR assay may permit accurate quantiﬁcation of
ﬁbril formation in the presence of ThT-interfering
compounds, provided that any inherent absorptive
properties of the additives can be accounted for.
With that in mind, an experiment similar to the ThT
ﬂuorescence assay shown in Figure 1 was performed,
using CR spectral shift (i.e. measurement of the absorbance at 540 nm upon the addition of 20 lm CR) to
quantify ﬁbril formation before and after incubation,
and therefore to determine the anti-ﬁbril effect of the
polyphenols. The CR absorbance at 540 nm was
recorded for samples of fresh native RCMj-CN

(50 lm) and RCMj-CN (50 lm) incubated at 37 C
for 20 h in the presence and absence of curcumin,
quercetin or resveratrol at the highest concentration
used previously (100 lm) (Fig. 4B). The absorbance
of RCMj-CN alone increased signiﬁcantly following
incubation, which is indicative of CR binding to
RCMj-CN ﬁbrils. All three polyphenols appeared to
have similarly poor efﬁcacy to prevent the formation of
b-sheet structures capable of binding to CR. Treatment
with quercetin showed the greatest reduction in CR
absorbance at 540 nm compared with RCMj-CN alone
(14 ± 4%). These ﬁndings were consistent with both
the TEM data, which showed that all the polyphenols
studied had a similar effect on RCMj-CN aggregation
(Fig. 2), and the seemingly unbiased real-time ThT
assay for RCMj-CN with resveratrol, which showed a
weak anti-aggregation action (Fig. 1C). Hence, it appears that although curcumin, quercetin and resveratrol
signiﬁcantly modulate the morphology of RCMj-CN
ﬁbril formation, their presence yields little inhibition of
the formation of b-sheet-rich structures.

Discussion
In this study, it is shown that ThT ﬂuorescence (excitation and emission maxima at approximately 440 and
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490 nm, respectively) should be used with caution
when quantifying amyloid ﬁbril formation in the presence of exogenous additives such as polyphenols. By
employing both single time-point dilution ThT assays
and in situ real-time ThT assays in the presence of
standard assay concentrations of curcumin, quercetin
and resveratrol, we demonstrated that such compounds can signiﬁcantly bias ﬁbril-associated ThT
ﬂuorescence.
Quercetin was strongly absorptive in the spectral
region of ThT ﬂuorescence (Fig. 3A) and at higher
concentrations (relative to the concentration of ﬁbrils)
led to severe inner ﬁlter effects and concentrationdependent quenching of the ThT ﬂuorescence intensity
(Fig. 1B, 3B and 3F). Free solvated curcumin was also
highly absorptive in the spectral range of ThT
(Fig. 3A). In addition, whilst curcumin is only weakly
ﬂuorescent in water, it becomes highly ﬂuorescent in
hydrophobic environments, such as when it interacts
with an amyloidogenic protein (Fig. 3E) [22,39]. Based
on studies of curcumin and other hydrophobic proteins, including human serum albumin and bovine
serum albumin, it is believed that such hydrophobic
species act as vehicles in which curcumin is carried and
protected from exposure to solvent [22,39]. These ﬂuorescent properties of curcumin also overlapped the
wavelengths of ThT ﬂuorescence (Fig. 3E). Hence, the
in situ real-time ThT ﬂuorescence assay was affected
by both the strong absorptive and ﬂuorescent properties of free curcumin and solvent-shielded curcumin,
respectively (depending on its concentration, compare
Fig. 1D with Fig. 3D). However, in the absence of sufﬁcient amyloid ﬁbrils to elicit curcumin ﬂuorescence,
as was the case in the single-point dilution ThT assay,
the absorptive properties of curcumin dominate and
a concentration-dependent quenching effect was
observed (Fig. 3H). Importantly, in the presence of
ﬁbrillar amyloid-b(1-42) (0.5 lm) and ﬁbrillar reduced
and carboxymethylated j-casein (RCMj-CN) (50 lm)
the biasing effects of curcumin were found to extend
to curcumin concentrations as low as 0.01 and 1 lm,
respectively (Fig. 3D,H).
Resveratrol had no signiﬁcant absorption within the
spectral ranges of ThT ﬂuorescence (Fig. 3A). The
real-time ThT assay for RCMj-CN treated with resveratrol thus appears to be able to quantify ﬁbril formation, indicating that resveratrol does not prevent
RCMj-CN aggregation efﬁciently (Fig. 1C and 3C).
However, in the dilution ThT assay, resveratrol at
higher concentrations (5 lm) signiﬁcantly decreased
the ThT ﬂuorescence induced by ﬁbrillar amyloid-b
(1-42) (Fig. 3G), suggesting that nonspectroscopic
effects of polyphenols can also play a role in biasing
5968

ThT ﬂuorescence. As this interfering effect was
observed immediately after the addition of resveratrol
to the ThT-ﬁbrillar amyloid-b(1-42) complex, and its
magnitude did not change over time, it is unlikely to
be attributable to ﬁbril dissolution. Rather, the results
suggest that either resveratrol interacts directly with
ThT (in the amyloid-bound or unbound state),
decreasing its ﬂuorescence intensity, or resveratrol
competitively binds with ThT for b-sheet-rich sites
along the length of ﬁbrils and is able to displace ThT
from these sites. This ﬁnding is perhaps not unexpected in light of the similar aromatic structures of
ThT and polyphenols (Fig. 1A).
The nonspectral biases identiﬁed using resveratrol
are an important ﬁnding of this work because they
indicate that an exogenous compound added in ThT
ﬂuorescence assays does not necessarily have to be
spectroscopically active to bias the ThT ﬂuorescence
response. For example, one concern is that because
ThT exists in micelles at the concentrations used to
monitor amyloid ﬁbrils ( 5–20 lm) [41,47], and the
added compounds that modulate ﬁbril formation are
often hydrophobic (a property which helps direct them
towards the inherently hydrophobic amyloid core),
they are likely to incorporate themselves into the ThT
micelles, which may affect the solution-state spectroscopic properties of the ThT [47]. Hence, the results
presented herein clearly highlight the need to investigate for interference to ThT ﬂuorescence when any
extrinsic compound is to be used in combination with
the ThT chromophore. This is, of course, particularly
relevant for conjugated aromatic molecules such as
polyphenols, which are typically spectroscopically
active in the ThT ﬂuorescence range. Assessment
should ﬁrst involve establishing any UV-visible absorbance and ﬂuorescence properties of the exogenous
compound in the presence and absence of preformed
ﬁbrils (at the intended ThT assay concentrations), to
ensure that there is no spectral activity in the regions
of 440 and 490 nm. Additional, nonspectroscopicbased interference of ThT ﬂuorescence should then be
investigated by adding the exogenous compound to
samples of preformed ﬁbrils and ThT, and monitoring
for any changes in the ThT ﬂuorescence emission
spectra over short time frames.
Herein, we also explored the use of the CR dye spectral shift assay (absorbance at 540 nm) as a potential
alternative to the ThT ﬂuorescence assays. It was
found that the absorptive contributions of the three
studied polyphenols could be accounted for via subtraction in this assay and therefore allowed the quantiﬁcation of ﬁbril formation (Fig. 4A). In using this
technique to assess the anti-amyloid activity of the
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polyphenols (Fig. 4B), it was shown that the polyphenols are all poorly efﬁcacious at preventing RCMj-CN
from forming b-sheet structures to which CR is capable of binding. Complementary TEM analysis indicated that despite their weak ability to inhibit b-sheet
formation, the polyphenols dramatically alter the morphology of RCMj-CN aggregation (Fig. 2). Their
presence yields a combination of stunted ﬁbrillar and
preﬁbrillar RCMj-CN assemblies, indicating that they
may interfere with the monomer ⁄ oligomer stacking
events that occur during ﬁbril elongation [1,2]. It is
worth noting that the CR spectral shift approach
assumes that even if the added exogenous compound
affects ﬁbril formation, its contribution to the CR
spectrum will remain unchanged. Furthermore, given
that the CR dye is also similarly aromatic in structure
to ThT [5], the potential for nonspectral interference
remains (even though we found no evidence of this in
our system). Therefore, in all circumstances where a
ﬁbril-forming polypeptide is in the presence of an
added exogenous compound, complementary methods
should be used to assess ﬁbril formation independently
of ThT ﬂuorescence and CR spectrophotometric assays
(e.g. electron microscopy or atomic force microscopy
to visualize ﬁbril morphology, X-ray ﬁbre diffraction
to conﬁrm cross-b-sheet structure, or even other optical techniques, such as using the mid-UV absorbance
of the peptide bond or intrinsic ﬂuorescence of the
added compound) [7,48–50].

Experimental Procedures
Materials
Unless speciﬁed otherwise, all materials and reagents used
were of analytical grade and were obtained from the Sigma
Chemical Company (St Louis, MO, USA). Black lClear
96-microwell plates were supplied by Greiner Bio-One
(Stonehouse, UK) and Thin Seal self-adhesive plate covers
were purchased from Excel Scientiﬁc (Chicago, IL, USA).
Carbon-coated 400-mesh nickel TEM grids were purchased
from SPI Supplies (West Chester, PA, USA) and uranyl
acetate was bought from Agar Scientiﬁc (Stansted, UK).
j-Casein was reduced and carboxymethylated as described
by Shechter et al. [51], with minor modiﬁcations as per
Farrell et al. [52]. Lyophilized RCMj-CN was stored at
)20 C and all solutions of native RCMj-CN were prepared in sodium phosphate buffer (50 mm, pH 7.4) at 4 C
immediately before use. The desired RCMj-CN concentration of 50 lm was achieved by standard spectrophotometric
methodology using a CARY 5000 UV-Vis-NIR spectrophotometer (Varian, CA, USA), a 1-cm path-length cuvette
and a molar extinction coefﬁcient of 0.95 mLÆmg)1Æcm)1 at
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280 nm [53]. Fibrillar RCMj-CN solutions (50 lm) were
prepared by pre-incubating native RCMj-CN solutions
(50 lm) at 37 C for 20 h to permit the formation of
mature amyloid ﬁbrils [35,36]. Amyloid-b(1-42) was
purchased from AnaSpec Inc. (San Jose, CA, USA) and a
1-mg sample was reconstituted in 60 lL of ammonium
hydroxide buffer (1%), as directed by the manufacturer.
The reconstituted peptide was then diluted in sodium phosphate buffer (50 mm, pH 7.4) to 25 lm and incubated at
37 C for 4 h with vigorous shaking to induce the formation of mature amyloid-b(1-42) ﬁbrils. After ﬁbrillation, the
ﬁbril solution was diluted to the desired concentration of
0.5 lm in glycine-NaOH buffer (50 mm, pH 8.5) to enhance
the ThT ﬂuorescence induced by the dilute amyloid-b(1-42)
ﬁbrils [23]. MilliQ water and all buffers were ﬁltered using
a 0.2 lm syringe ﬁlter before use.

Preparation of samples for assay
The polyphenols, curcumin, quercetin and resveratrol, were
ﬁrst solubilized in dimethylsulfoxide to stock concentrations
of 0.001, 0.01, 0.1, 0.5, 1, 3, 5 and 10 mm. To achieve the
desired molar ratio of polyphenol to native or ﬁbrillar protein (as indicated in each ﬁgure), the polyphenol stocks were
added to protein solutions (prepared as described above)
such that the ﬁnal concentration of dimethylsulfoxide was
1% (v ⁄ v) and the protein solution was not signiﬁcantly
diluted. The residual concentration of dimethylsulfoxide was
conﬁrmed to have no signiﬁcant effect on ﬁbrillation or
ThT ⁄ CR binding (data not shown). Both quercetin and
curcumin are not soluble above 100 lm without using higher
concentrations of dimethylsulfoxide. Samples of polyphenol
alone were prepared by substituting the protein solution for
the same volume of sodium phosphate buffer. Where appropriate, ThT (5 or 10 lm) or CR (20 lm) was added to the
samples immediately before the assay from stock solutions
of ThT and CR (200 lm) prepared in the appropriate assay
buffer. It was established that a ratio of 20 lm CR to 50 lm
native and ﬁbrillar samples of RCMj-CN resulted in the
most practicable and detectable change in CR absorbance at
540 nm as a result of the presence of ﬁbrils (data not shown)
and these concentrations were therefore used in these
experiments.

In situ ThT fluorescence assay
Samples (200 lL) with ThT were incubated at 37 C in
black lClear 96-microwell plates that were sealed to
prevent evaporation. The ThT ﬂuorescence intensity of
each sample was recorded every 5 min using a FLUOstar
OPTIMA plate reader (BMG Labtechnologies, Melbourne,
VIC, Australia) with 440 ⁄ 490-nm excitation ⁄ emission ﬁlters
set. As native RCMj-CN binds some ThT as a result of
its b-sheet content [52], the ThT data were normalized by
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plotting the change in ThT ﬂuorescence (in arbitrary units,
a.u.), DF, as determined by the equation: DF = F–F30,
where F is the mean ThT ﬂuorescence reading (in arbitrary
units, a.u.) from triplicate experiments and F30 is the
mean ThT ﬂuorescence reading (in arbitrary units, a.u.)
after 30 min of incubation once all samples had evenly
equilibrated to 37 C. The presence of ThT at the concentration used did not affect RCMj-CN ﬁbril formation
[35].

TEM
Aliquots (2 lL) were taken from samples of the in situ ThT
ﬂuorescence assays, before or after the 1100 min incubation
period (as indicated in each ﬁgure), and were transferred
onto the surface of carbon-coated 400-mesh nickel TEM
grids. The grid surface was then washed with MilliQ water
passed through a 0.2-lm syringe ﬁlter (3 · 10 lL) and negatively stained with 10 lL of uranyl acetate solution [2%
(w ⁄ v), in MilliQ water]. Between each wash, and after staining, excess solution was removed by blotting with ﬁlter
paper. The grid was left to air dry and was then viewed
under 25 000–64 000· magniﬁcation using a Philips CM100
Transmission Electron Microscope (Philips, Eindhoven, the
Netherlands) with an 80 kV excitation voltage.

Absorption and fluorescence emission spectra
UV-visible solution-state absorption spectra, or singlewavelength absorbance of samples with and without ThT
or CR (as indicated in each ﬁgure), were recorded using a
CARY 5000 UV-Vis-NIR spectrophotometer and 0.2-cm
path-length cuvettes. Steady-state ﬂuorescence emission
spectra of samples were acquired using a Cary Eclipse
ﬂuorescence spectrophotometer (Varian, CA, USA) and a
0.2-cm path-length cuvette with the excitation and emission slit widths set at 10 and 20 nm, respectively. All
absorption and ﬂuorescence spectra were recorded at room
temperature to prevent signiﬁcant amyloid ﬁbril formation
by RCMj-CN over the period of spectral acquisition. The
absorption spectrum of buffer was subtracted from all
sample absorption spectra. Fluorescence emission spectra
were corrected for minor contributions from scattered
excitation radiation by subtracting the spectrum of buffer
alone.
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